Is Pulmonary Artery Pressure a Trigger of Adverse Outcome in Mitral Regurgitation?

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2017 Feb 3

PMID 28149860

Authors

Iside Scarfo

Giovanni La Canna

Affiliations

Soon will be listed here.

References

Blondheim D, Osipov A, Meisel S, Frimerman A, Shochat M, Shotan A . Relation of left atrial size to function as determined by transesophageal echocardiography. Am J Cardiol. 2005; 96(3):457-63. DOI: 10.1016/j.amjcard.2005.03.101. View

Gillam L, Marcoff L, Shames S . Timing of surgery in valvular heart disease: prophylactic surgery vs watchful waiting in the asymptomatic patient. Can J Cardiol. 2014; 30(9):1035-45. DOI: 10.1016/j.cjca.2014.06.019. View

Lancellotti P, Rosenhek R, Pibarot P, Iung B, Otto C, Tornos P . ESC Working Group on Valvular Heart Disease position paper--heart valve clinics: organization, structure, and experiences. Eur Heart J. 2013; 34(21):1597-606. DOI: 10.1093/eurheartj/ehs443. View

Alexopoulos D, Lazzam C, Borrico S, Fiedler L, Ambrose J . Isolated chronic mitral regurgitation with preserved systolic left ventricular function and severe pulmonary hypertension. J Am Coll Cardiol. 1989; 14(2):319-22. DOI: 10.1016/0735-1097(89)90180-0. View

Goldstone A, Patrick W, Cohen J, Aribeana C, Popat R, Woo Y . Early surgical intervention or watchful waiting for the management of asymptomatic mitral regurgitation: a systematic review and meta-analysis. Ann Cardiothorac Surg. 2015; 4(3):220-9. PMC: 4533073. DOI: 10.3978/j.issn.2225-319X.2015.04.01. View

Magne J, Lancellotti P, Pierard L . Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation. 2010; 122(1):33-41. DOI: 10.1161/CIRCULATIONAHA.110.938241. View

Montant P, Chenot F, Robert A, Vancraeynest D, Pasquet A, Gerber B . Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: a propensity score-based comparison between an early surgical strategy and a conservative treatment approach. J Thorac Cardiovasc Surg. 2009; 138(6):1339-48. DOI: 10.1016/j.jtcvs.2009.03.046. View

Barbieri A, Bursi F, Grigioni F, Tribouilloy C, Avierinos J, Michelena H . Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur Heart J. 2010; 32(6):751-9. DOI: 10.1093/eurheartj/ehq294. View

Mentias A, Patel K, Patel H, Gillinov A, Sabik J, Mihaljevic T . Effect of Pulmonary Vascular Pressures on Long-Term Outcome in Patients With Primary Mitral Regurgitation. J Am Coll Cardiol. 2016; 67(25):2952-61. DOI: 10.1016/j.jacc.2016.03.589. View

10.

Bergler-Klein J, Gyongyosi M, Maurer G . The role of biomarkers in valvular heart disease: focus on natriuretic peptides. Can J Cardiol. 2014; 30(9):1027-34. DOI: 10.1016/j.cjca.2014.07.014. View

11.

Yang H, Davidson Jr W, Chambers C, Pae W, Sun B, Campbell D . Preoperative pulmonary hypertension is associated with postoperative left ventricular dysfunction in chronic organic mitral regurgitation: an echocardiographic and hemodynamic study. J Am Soc Echocardiogr. 2006; 19(8):1051-5. DOI: 10.1016/j.echo.2006.03.016. View

12.

Magne J, Pibarot P, Sengupta P, Donal E, Rosenhek R, Lancellotti P . Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group. JACC Cardiovasc Imaging. 2015; 8(1):83-99. DOI: 10.1016/j.jcmg.2014.12.003. View

13.

Galie N, Humbert M, Vachiery J, Gibbs S, Lang I, Torbicki A . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):.... Eur Heart J. 2015; 37(1):67-119. DOI: 10.1093/eurheartj/ehv317. View

14.

Le Tourneau T, Messika-Zeitoun D, Russo A, Detaint D, Topilsky Y, Mahoney D . Impact of left atrial volume on clinical outcome in organic mitral regurgitation. J Am Coll Cardiol. 2010; 56(7):570-8. DOI: 10.1016/j.jacc.2010.02.059. View

15.

Le Tourneau T, Richardson M, Juthier F, Modine T, Fayad G, Polge A . Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart. 2010; 96(16):1311-7. DOI: 10.1136/hrt.2009.186486. View

16.

Ghoreishi M, Evans C, deFilippi C, Hobbs G, Young C, Griffith B . Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery. J Thorac Cardiovasc Surg. 2011; 142(6):1439-52. DOI: 10.1016/j.jtcvs.2011.08.030. View

17.

Vahanian A, Alfieri O, Andreotti F, Antunes M, Baron-Esquivias G, Baumgartner H . Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012; 33(19):2451-96. DOI: 10.1093/eurheartj/ehs109. View

18.

Lancellotti P, Fattouch K, La Canna G . Therapeutic decision-making for patients with fluctuating mitral regurgitation. Nat Rev Cardiol. 2015; 12(4):212-9. DOI: 10.1038/nrcardio.2015.16. View

19.

Nkomo V, Gardin J, Skelton T, Gottdiener J, Scott C, Enriquez-Sarano M . Burden of valvular heart diseases: a population-based study. Lancet. 2006; 368(9540):1005-11. DOI: 10.1016/S0140-6736(06)69208-8. View

20.

Nishimura R, Otto C, Bonow R, Carabello B, Erwin 3rd J, Guyton R . 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63(22):2438-88. DOI: 10.1016/j.jacc.2014.02.537. View